Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program

por Cohen, Joel L., Green, Lawrence J., Beer, Kenneth R., Liu, Yan, Gallagher, Conor J.
Publicado 2021

Improvements in Submental Contour up to 3 Years After ATX-101: Efficacy and Safety Follow-Up of the Phase 3 REFINE Trials

por Humphrey, Shannon, Cohen, Joel L, Bhatia, Ashish C, Green, Lawrence J, Green, Jeremy B, Bowen, Beta
Publicado 2021

Silica-based microencapsulation used in topical dermatologic applications

por Green, Lawrence J., Bhatia, Neal D., Toledano, Ofer, Erlich, Maya, Spizuoco, Amy, Goodyear, Benjamin C., York, Jean Philippe, Jakus, Jeannette
Publicado 2023

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study

por Fabi, Sabrina G., Cohen, Joel L., Green, Lawrence J., Dhawan, Sunil, Kontis, Theda C., Baumann, Leslie, Gross, Todd M., Gallagher, Conor J., Brown, Jessica, Rubio, Roman G.
Publicado 2021

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial

por Zirwas, Matthew J., Draelos, Zoe D., DuBois, Janet, Kircik, Leon H., Moore, Angela Y., Stein Gold, Linda, Alonso-Llamazares, Javier, Bukhalo, Michael, Bruce, Suzanne, Eads, Kimmie, Green, Lawrence J., Guenthner, Scott T., Ferris, Laura K., Forman, Seth B., Kempers, Steven E., Lain, Edward, Lynde, Charles W., Pariser, David M., Toth, Darryl P., Yamauchi, Paul S., Higham, Robert C., Krupa, David, Burnett, Patrick, Berk, David R.
Publicado 2023